Login
From:
ALS News Today
(Uncensored)
subscribe
CNM-Au8 shows survival benefit after 3.5 years: Analysis
https://alsnewstoday.com/news/cnm-au8-shows-survival-benefit-after-3-5-years-analysis/
links
backlinks
Tagged with:
als survival outcomes
clene nanomedicine
cnm-au8
The risk of death was nearly 60% lower in ALS patients given the experimental oral therapy CNM-Au8 than for an external placebo group, data show.
Roast topics
Find topics
Find it!
